An Indian Drugmaker, Investigated by ProPublica Last Year, Has Recalled Two Dozen Medications Sold to U.S. Patients

The FDA found problems with cleaning and testing at the plant in Madhya Pradesh , India , which was the subject of a ProPublica investigation last year .

The FDA determined that the drugs could cause temporary or reversible harm and that the chance of more serious problems was remote.

The recalls cover a wide range of commonly prescribed medicines, including ones that treat epilepsy, diabetes, multiple sclerosis and heart disease.

Glenmark is embroiled in a federal lawsuit that alleges recalled potassium chloride capsules made at its Madhya Pradesh factory caused the death of a 91-year-old Maine woman in June .

The FDA had determined last year that more than 50 million of those recalled extended-release capsules had the potential to kill U.S. patients because they didn’t dissolve correctly.